Evanthia Galanis, M.D.

  1. Oncologist

Departments

Specialty Groups

Location

  1. Rochester, Minnesota

Languages

English
Rochester

Rochester, Minnesota

  1. 1998
    ResidentHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 1998
    Fellow - Hematology/OncologyMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  3. 1994
    ResidentInternal Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  4. 1994
    Resident - Internal MedicineMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  5. 1993
    D.Sc - ""Development and application of quantitative immunoenzymatic assays (ELISAS) and immunoblotting techniques in the study of specificity and title of M1- antimitochondrial antibodies (M2-AMA).Athens University School of Medicine, Athens
  6. 1990
    MDAthens University School of Medicine, Athens

Certifications

  1. 1997
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2023
    Victor Levin Award for Achievement in Neuro-OncologyThe Society for Neuro-Oncology
  2. 2023
    Professor Honoris CausaNational and Kapodistrian University of Athens
  3. 2020
    Distinguished Mayo Clinic Investigator AwardMayo Clinic
  4. 2013
    Sandra J. Schulze ProfessorshipSandra J. Schulze Professorship
  5. 2011
    Elected MemberAmerican Society of Clinical Investigation
  6. 2005
    Award of Excellence13th International Conference on Gene Therapy
  7. 1998
    AACR/Glaxo Wellcome AwardAmerican Association for Cancer Research
  8. 1998
    Outstanding Achievement Award in OncologyMayo Clinic
  9. 1997
    Award on Genetics in OncologyBerlex Oncology Foundation
  10. 1997
    Award on Clinical Pharmacology of Anticancer DrugsBerlex Oncology Foundation
  11. 1997
    Linse-Bock Fellowship in Neuro-OncologyAwarding Organization
  12. 1997
    AACR ScholarshipAACR Molecular Biology Workshop
  13. 1996
    Award on Epidemiology and Clinical Trial DesignBerlex Oncology Foundation
  14. 1994
    Internal Medicine Outstanding Research AwardMayo Graduate School of Medicine, Mayo Clinic College of Medicine and Science, Department of Education Administration
  15. 1990
    ValedictorianUniversity of Athens Medical School
  16. 1990
    Scholarship for Completion of D.Sc ThesisGreek Ministry of Public Health
  17. 1984
    Yearly ScholarshipsGreek Ministry of Education/National Scholarship Foundation

Professional memberships

  1. 2023 - present
    Group ChairAlliance for Clinical Trials in Oncology
  2. 2022 - 2023
    MemberBold. Forward. Unbound. in Rochester Advisory Group, Clinical Practice Committee, Mayo Clinic Rochester Executive Operations Team
  3. 2021 - present
    Co-chair, National ConferenceAmerican Brain Tumor Association
  4. 2021 - 2023
    2023 Scientific Committee Member, CNS Tumours TrackEuropean Society for Medical Oncology
  5. 2021 - 2022
    IOVC Organizing Committee, MemberAmerican Society of Gene and Cell Therapy
  6. 2021 - present
    MemberEuropean Organisation for Research and Treatment of Cancer, Protocol Review Committee
  7. 2021 - present
    Lead, CNS TrackAmerican Society of Clinical Oncology, ASCO Scientific Program Committee
  8. 2020 - present
    MemberMayo Clinic Proceedings Business Advisory Board
  9. 2020 - present
    Chair, External Advisory CommitteeMassachusetts General Hospital, K12 Training Grant in Neurooncology
  10. 2020 - present
    Co-Chair, Awards CommitteeSociety for Neuro-Oncology
  11. 2019 - 2023
    ConsultantCellular, Tissue and Gene Therapies Advisory Committee, Food and Drug Administration
  12. 2019
    IOVC Organizing Committee, MemberAmerican Society of Gene and Cell Therapy
  13. 2019 - present
    MemberMedical Industry Relations Committee, Mayo Clinic Rochester Committees
  14. 2019 - present
    Lead, CNS TrackAmerican Society of Clinical Oncology, ASCO Scientific Program Committee
  15. 2018 - present
    Co-Leader, Brain Cancer InitiativeNational Cancer Institute, Food and Drug Administration, Novel Therapeutics Working Group
  16. 2018 - present
    MemberMayo Clinic Research Committee, Mayo Clinic Committees
  17. 2018 - present
    Program Committee MemberAnnual Meeting Scientific Program Committee, American Society of Clinical Oncology
  18. 2017 - present
    MemberExecutive Committee, Virus and Gene Therapy Program, Mayo Graduate School; Virus and Gene Therapy Program; Executive Committee
  19. 2017 - present
    MemberMayo Extramural Research Partnership (MERP) Executive Office
  20. 2017 - present
    Industry Arm LeaderMayo Extramural Research Partnership (MERP) Executive Office
  21. 2017 - present
    Board MemberNational Brain Tumor Society
  22. 2016 - 2017
    ChairMayo Clinic Committees, Recruitment Package Task Force
  23. 2016 - 2017
    Co-ChairT-VEC (Talimogene Laherparepvec) Project Team, National Cancer Institute, National Institutes of Health
  24. 2016 - present
    MemberNamed Professorship Committee - Mayo Clinic, Mayo Clinic Committees
  25. 2016 - 2022
    MemberNamed Professorship Committee - Mayo Clinic, Mayo Clinic Committees
  26. 2016 - 2017
    MemberAmerican Society of Clinical Oncology, Clinical Practice Guideline Panel for Radiation Therapy for Glioblastoma
  27. 2015 - present
    MemberClinical Outcome Assessment Messaging Working Group, National Brain Tumor Association
  28. 2015 - present
    MemberMayo Clinic Hepatobiliary SPORE, Internal Scientific Advisory Committee
  29. 2015 - 2017
    MemberT-VEC (Talimogene Laherparepvec) Project Team, National Cancer Institute, National Institutes of Health
  30. 2015 - present
    Co-ChairNational Institutes of Health, National Cancer Institute, Glioblastoma/Brain Metastases Interest Group
  31. 2014 - present
    MemberMayo Clinic SPORE in Pancreatic Cancer, Internal Scientific Advisory Committee
  32. 2014 - 2015
    MemberClinical Outcome Assessment Endpoints Workshop, National Brain Tumor Association
  33. 2014 - present
    MemberBrain Tumor Imaging Standardization Steering Committee, National Brain Tumor Association
  34. 2013 - 2015
    MemberSociety for Neuro-Oncology, Executive Committee
  35. 2013 - 2015
    Secretary/TreasurerSociety for Neuro-Oncology
  36. 2013 - present
    MemberMayo Clinic Scientific Advisory Council, Mayo Clinic Research Committee, Mayo Clinic Committees
  37. 2013 - present
    MemberAdvisory Council to the Executive Dean for Research, Mayo Clinic Committees
  38. 2013 - present
    MemberTranslational Oversight Group, Center for Regenerative Medicine, Mayo Clinic Committees
  39. 2013 - 2023
    Abstract ReviewerAnnual Meeting, Society for Neuro-Oncology
  40. 2013 - 2017
    US LeadRare Brain Tumour Group, International Rare Cancer Initiative
  41. 2013
    ChairAmerican Society of Gene and Cell Therapy, Targeted Cancer Gene and Cell Therapy Abstract Review Committee
  42. 2011 - present
    External Advisory Board MemberMD Anderson Cancer Center, Brain SPORE
  43. 2011 - 2019
    Abstract ReviewerAmerican Society of Gene and Cell Therapy
  44. 2011 - 2020
    Program LeaderMayo Clinic Cancer Center, Mayo Clinic Cancer Center - Rochester, Gene and Virus Therapy Program
  45. 2011 - 2023
    ChairNeuro-Oncology Committee, Alliance for Clinical Trials in Oncology
  46. 2011 - 2018
    MemberCancer Gene & Cell Therapy Committee, American Society of Gene and Cell Therapy
  47. 2011 - present
    MemberAlliance for Clinical Trials in Oncology
  48. 2011 - present
    Elected MemberAmerican Society of Clinical Investigation
  49. 2010
    ChairSite Visit Team, Food and Drug Administration
  50. 2010 - present
    MemberBrain Malignancies Steering Committee, National Cancer Institute, National Institutes of Health
  51. 2010
    MemberSite Visit Team, Food and Drug Administration
  52. 2009 - 2011
    MemberInternal Scientific Advisory Committee, Mayo Clinic Breast SPORE, Mayo Clinic Cancer Center
  53. 2009 - 2015
    ConsultantCellular, Tissue and Gene Therapies Advisory Committee, Food and Drug Administration
  54. 2009 - present
    Scientific ReviewerEuropean Research Council
  55. 2009 - 2011
    MemberSociety for Neuro-Oncology, Medical Oncology Representative, Board of Directors
  56. 2009 - 2011
    Co-ChairNeuro-Oncology Committee, North Central Cancer Treatment Group
  57. 2008 - present
    MemberResponse Assessment in Neurooncology Working Group
  58. 2007 - present
    Full MemberMayo Clinic Center for Translational Science Activities
  59. 2007
    Vice ChairResearch Resources Review Committee, Mayo Clinic Center for Translational Science Activities
  60. 2007
    ChairClinical and Experimental Therapeutics #2, United States Department of Defense
  61. 2007 - present
    MemberAcademic Affairs Committee, Mayo Clinic Center for Translational Science Activities
  62. 2005 - 2010
    MemberCTEP Concept Review Committee, National Cancer Institute, National Institutes of Health
  63. 2005 - 2006
    MemberClinical Research Subcommittee, Mayo Clinic Committees
  64. 2004 - 2006
    Advisory Board MemberGeneral Clinical Research Center Advisory Committee, Mayo Clinic Committees
  65. 2004 - present
    MemberInternational Working Group for Gene Therapy
  66. 2003
    MemberCancer Center Site Visit Audit Team, National Cancer Institute, National Institutes of Health
  67. 2002 - 2008
    Vice ChairNeuro-Oncology Committee, North Central Cancer Treatment Group
  68. 2000 - 2005
    Review Panel MemberClinical and Experimental Therapeutics #4, United States Department of Defense
  69. 2000 - 2002
    MemberHematology/Oncology Fellowship Selection Committee, Department of Oncology
  70. 2000 - 2001
    MemberEducation Committee, Division of Medical Oncology, Department of Oncology
  71. 2000 - 2001
    MemberGene Therapy Committee, Greek Ministry of Health
  72. 2000 - present
    MemberResearch Committee, Division of Medical Oncology, Department of Oncology
  73. 1999 - 2011
    MemberNovel Therapeutics Committee, North Central Cancer Treatment Group
  74. 1999 - present
    MemberSociety for Neuro-Oncology
  75. 1998 - 2008
    MemberOncology Review Committee (Previously, Protocol Review Committee), Mayo Clinic Cancer Center Committees, Mayo Clinic Cancer Center
  76. 1998 - present
    MemberNorth Central Cancer Treatment Group
  77. 1997 - present
    MemberAmerican Society of Gene and Cell Therapy
  78. 1996 - present
    MemberAmerican Association for Cancer Research
  79. 1996 - present
    MemberEuropean Association for Cancer Research
  80. 1996 - present
    MemberAmerican Society of Clinical Oncology
  81. 1996 - present
    MemberEuropean Society for Medical Oncology
  82. 1995 - 1998
    MemberAmerican College of Physicians
  83. 1994 - present
    Mayo Clinic Alumni Association, Mayo Clinic College of Medicine and Science, Department of Education Administration
  84. 1993 - present
    MemberHospital Albert Schweitzer Alumni Association
  85. 1991 - 1998
    MemberAmerican Medical Association
  86. 1990 - present
    MemberAthens Medical Association
  87.  
    MemberMayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center